{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:14:44Z","timestamp":1790651684200,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ajem.2020.05.024","type":"journal-article","created":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T12:19:22Z","timestamp":1589631562000},"page":"1549.e3-1549.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":158,"title":["Neurologic complications of COVID-19"],"prefix":"10.1016","volume":"38","author":[{"given":"Rachel","family":"Bridwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2020.05.024_bb0005","author":"World Health Organization"},{"key":"10.1016\/j.ajem.2020.05.024_bb0015","author":"World Health Organization"},{"issue":"3","key":"10.1016\/j.ajem.2020.05.024_bb0020","article-title":"Neurological complications of coronavirus disease (COVID-19): encephalopathy","volume":"12","author":"Filatov","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ajem.2020.05.024_bb0025","doi-asserted-by":"crossref","DOI":"10.1111\/ene.14257","article-title":"The need for neurologists in the care of COVID-19 patients","author":"Sellner","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ajem.2020.05.024_bb0030","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000009673","article-title":"Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19","author":"Herman","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.ajem.2020.05.024_bb0035","doi-asserted-by":"crossref","unstructured":"Nath A. Neurologic complications of coronavirus infections. Neurology. March 2020:https:\/\/doi.org\/10.1212\/WNL.0000000000009455. doi:https:\/\/doi.org\/10.1212\/wnl.0000000000009455.","DOI":"10.1212\/WNL.0000000000009455"},{"issue":"13","key":"10.1016\/j.ajem.2020.05.024_bb0040","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA - J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.ajem.2020.05.024_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-019-1182-0","article-title":"Coronavirus envelope protein: current knowledge","volume":"16","author":"Schoeman","year":"2019","journal-title":"Virol J"},{"issue":"1","key":"10.1016\/j.ajem.2020.05.024_bb0050","article-title":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)","volume":"7","author":"Jin","year":"2020","journal-title":"Mil Med Res"},{"issue":"2","key":"10.1016\/j.ajem.2020.05.024_bb0055","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.ajem.2020.05.024_bb0060","doi-asserted-by":"crossref","unstructured":"Wan S, Yi Q, Fan S, et al. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). medRxiv. February 2020:2020.02.10.20021832. doi:https:\/\/doi.org\/10.1101\/2020.02.10.20021832.","DOI":"10.1101\/2020.02.10.20021832"},{"key":"10.1016\/j.ajem.2020.05.024_bb0065","article-title":"Nervous system involvement after infection with COVID-19 and other coronaviruses","author":"Wu","year":"2020","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.ajem.2020.05.024_bb0070","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak- a n update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil Med Res"},{"issue":"1","key":"10.1016\/j.ajem.2020.05.024_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/v12010014","article-title":"Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?","volume":"12","author":"Desforges","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.ajem.2020.05.024_bb0080","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.0c00181","article-title":"Updates on what ACS reported: emerging evidences of COVID-19 with nervous system involvement","author":"Baig","year":"2020","journal-title":"ACS Chem Nerosci"},{"key":"10.1016\/j.ajem.2020.05.024_bb0085","doi-asserted-by":"crossref","DOI":"10.1007\/s12250-020-00207-4","article-title":"Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools","author":"Fu","year":"2020","journal-title":"Virol Sin"},{"key":"10.1016\/j.ajem.2020.05.024_bb0090","series-title":"Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: A retrospective case series study. medRxiv","author":"Mao","year":"2020"},{"key":"10.1016\/j.ajem.2020.05.024_bb0095","article-title":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China","author":"Mo","year":"2020","journal-title":"Clin Infect Dis March"},{"issue":"11","key":"10.1016\/j.ajem.2020.05.024_bb0100","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA - J Am Med Assoc"},{"key":"10.1016\/j.ajem.2020.05.024_bb0105","article-title":"Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study","author":"Du","year":"2020","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.ajem.2020.05.024_bb0110","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/jcm9020575","article-title":"Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China","volume":"9","author":"Deng","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajem.2020.05.024_bb0115","doi-asserted-by":"crossref","unstructured":"Aggarwal G, Lippi G, Michael Henry B. Cerebrovascular disease is associated with an increased disease severity in patients with coronavirus disease 2019 (COVID-19): a pooled analysis of published literature. Int J Stroke. April 2020:1747493020921664. doi:https:\/\/doi.org\/10.1177\/1747493020921664.","DOI":"10.1177\/1747493020921664"},{"key":"10.1016\/j.ajem.2020.05.024_bb0120","first-page":"1","article-title":"Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study","author":"Li","year":"2020","journal-title":"SSRN Electron J"},{"key":"10.1016\/j.ajem.2020.05.024_bb0125","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ajem.2020.05.024_bb0130","article-title":"The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients","author":"Li","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.ajem.2020.05.024_bb0135","doi-asserted-by":"crossref","DOI":"10.1111\/ene.14286","article-title":"Emergency room neurology in times of COVID-19: malignant ischemic stroke and SARS-COV2 infection","author":"Gonz\u00e1lez-Pinto","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ajem.2020.05.024_bb0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","article-title":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy","volume":"191","author":"Lodigiani","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajem.2020.05.024_bb0145","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajem.2020.05.024_bb0150","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2009787","article-title":"Large-vessel stroke as a presenting feature of Covid-19 in the young","author":"Oxley","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajem.2020.05.024_bb0155","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/ene.12601","article-title":"Previous infection and the risk of ischaemic stroke in Italy: the IN2 study","volume":"22","author":"Consoli","year":"2015","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.ajem.2020.05.024_bb0160","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/1570161113666150923111329","article-title":"Anti-inflammatory strategies in stroke: a potential therapeutic target","volume":"14","author":"Siniscalchi","year":"2015","journal-title":"Curr Vasc Pharmacol"},{"issue":"2","key":"10.1016\/j.ajem.2020.05.024_bb0165","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1515\/jbcpp-2013-0121","article-title":"Cerebral stroke injury: the role of cytokines and brain inflammation","volume":"25","author":"Siniscalchi","year":"2014","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"10.1016\/j.ajem.2020.05.024_bb0170","article-title":"Protected code stroke: Hyperacute stroke management during the coronavirus disease 2019 (COVID-19) pandemic","author":"Khosravani","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2020.05.024_bb0175","doi-asserted-by":"crossref","first-page":"104881","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104881","article-title":"Acute stroke care in the Coronavirus Disease 2019 pandemic","author":"Dafer","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.ajem.2020.05.024_bb0180","doi-asserted-by":"crossref","DOI":"10.1136\/neurintsurg-2020-016098","article-title":"Society of NeuroInterventional surgery recommendations for the care of emergent neurointerventional patients in the setting of covid-19","author":"Fraser","year":"2020","journal-title":"J Neurointerv Surg"},{"issue":"2","key":"10.1016\/j.ajem.2020.05.024_bb0185","first-page":"155","article-title":"Acute encephalitis - diagnosis and management","volume":"18","author":"Ellul","year":"2018","journal-title":"Clin Med J R Coll Physicians London"},{"key":"10.1016\/j.ajem.2020.05.024_bb0190","doi-asserted-by":"crossref","unstructured":"Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19\u2013associated acute Hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. March 2020:201187. doi:https:\/\/doi.org\/10.1148\/radiol.2020201187.","DOI":"10.1148\/radiol.2020201187"},{"key":"10.1016\/j.ajem.2020.05.024_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2020.04.017","article-title":"Encephalitis as a clinical manifestation of COVID-19","author":"Ye","year":"2020","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.ajem.2020.05.024_bb0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.nic.2007.12.007","article-title":"Imaging of acute disseminated encephalomyelitis","volume":"18","author":"Rossi","year":"2008","journal-title":"Neuroimaging Clin N Am"},{"issue":"9","key":"10.1016\/j.ajem.2020.05.024_bb0205","first-page":"1919","article-title":"Acute necrotizing encephalopathy of childhood: correlation of MR findings and clinical outcome","volume":"27","author":"Wong","year":"2006","journal-title":"Am J Neuroradiol"},{"issue":"3","key":"10.1016\/j.ajem.2020.05.024_bb0210","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/ofid\/ofx145","article-title":"Successful treatment of influenza-associated acute necrotizing encephalitis in an adult using high-dose oseltamivir and methylprednisolone: case report","volume":"4","author":"Alsolami","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ajem.2020.05.024_bb0215","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.0c00201","article-title":"Neurological insights of COVID-19 pandemic","author":"Das","year":"2020","journal-title":"ACS Chem Nerosci"},{"issue":"2","key":"10.1016\/j.ajem.2020.05.024_bb0220","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.ajem.2020.05.024_bb0225","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain\u2013Barr\u00e9 syndrome associated with SARS-CoV-2","author":"Toscano","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2020.05.024_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocn.2020.04.062","article-title":"Guillain Barre syndrome associated with COVID-19 infection: a case report","author":"Sedaghat","year":"2020","journal-title":"J Clin Neurosci"},{"issue":"5","key":"10.1016\/j.ajem.2020.05.024_bb0235","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence?","volume":"19","author":"Zhao","year":"2020","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ajem.2020.05.024_bb0240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","article-title":"Hemophagocytic lymphohistiocytosis","volume":"13","author":"Al-Samkari","year":"2018","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"10229","key":"10.1016\/j.ajem.2020.05.024_bb0245","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"issue":"10223","key":"10.1016\/j.ajem.2020.05.024_bb0250","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ajem.2020.05.024_bb0255","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the hscore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"0","key":"10.1016\/j.ajem.2020.05.024_bb0260","first-page":"0","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2020.05.024_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117477","article-title":"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19","volume":"248","author":"Elfiky","year":"2020","journal-title":"Life Sci"},{"issue":"0","key":"10.1016\/j.ajem.2020.05.024_bb0270","first-page":"0","article-title":"Coronavirus disease (COVID-19): a primer for emergency physicians","author":"Chavez","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2020.05.024_bb0275","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ajem.2020.04.048","article-title":"Cardiovascular complications in COVID-19","volume":"38","author":"Long","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2020.05.024_bb0280","author":"AbbVie Inc."},{"issue":"3","key":"10.1016\/j.ajem.2020.05.024_bb0285","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.antiviral.2010.10.006","article-title":"Metabolic and neurologic consequences of chronic lopinavir\/ritonavir administration to C57BL\/6 mice","volume":"88","author":"Pistell","year":"2010","journal-title":"Antiviral Res"},{"issue":"6","key":"10.1016\/j.ajem.2020.05.024_bb0290","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11096-005-1319-7","article-title":"Side effects of interferon-\u03b1 therapy","volume":"27","author":"Sleijfer","year":"2005","journal-title":"Pharm World Sci"},{"issue":"6","key":"10.1016\/j.ajem.2020.05.024_bb0295","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0016-5085(03)00394-9","article-title":"Side effects of therapy for chronic hepatitis C","volume":"124","author":"Russo","year":"2003","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.ajem.2020.05.024_bb0300","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ccr3.238","article-title":"Prolonged neuropsychiatric effects following management of chloroquine intoxication with psychotropic polypharmacy","volume":"3","author":"Maxwell","year":"2015","journal-title":"Clin Case Reports"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675720303648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675720303648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:50:35Z","timestamp":1760025035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675720303648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0735675720303648"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2020.05.024","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurologic complications of COVID-19","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2020.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}